These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 30884206)

  • 1. Candidate genes involved in metastasis of colon cancer identified by integrated analysis.
    Zhou Y; Zang Y; Yang Y; Xiang J; Chen Z
    Cancer Med; 2019 May; 8(5):2338-2347. PubMed ID: 30884206
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinguishable Prognostic Signatures of Left- and Right-Sided Colon Cancer: a Study Based on Sequencing Data.
    Liang L; Zeng JH; Qin XG; Chen JQ; Luo DZ; Chen G
    Cell Physiol Biochem; 2018; 48(2):475-490. PubMed ID: 30016783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrated bioinformatics analysis of key genes involved in progress of colon cancer.
    Yang H; Wu J; Zhang J; Yang Z; Jin W; Li Y; Jin L; Yin L; Liu H; Wang Z
    Mol Genet Genomic Med; 2019 Apr; 7(4):e00588. PubMed ID: 30746900
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A robust panel based on tumour microenvironment genes for prognostic prediction and tailoring therapies in stage I-III colon cancer.
    Zhou R; Zeng D; Zhang J; Sun H; Wu J; Li N; Liang L; Shi M; Bin J; Liao Y; Huang N; Liao W
    EBioMedicine; 2019 Apr; 42():420-430. PubMed ID: 30917936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microarray‑based analysis of COL11A1 and TWIST1 as important differentially‑expressed pathogenic genes between left and right‑sided colon cancer.
    Su C; Zhao J; Hong X; Yang S; Jiang Y; Hou J
    Mol Med Rep; 2019 Nov; 20(5):4202-4214. PubMed ID: 31545476
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An Integrated miRNA-lncRNA Signature Predicts the Survival of Stage II Colon Cancer.
    Wang XJ; Zeng B; Lin S; Chen M; Chi P
    Ann Clin Lab Sci; 2019 Nov; 49(6):730-739. PubMed ID: 31882423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification and clinical validation of metastasis-associated biomarkers based on large-scale samples in colon-adenocarcinoma.
    Gu L; Liu Y; Jiang C; Sun L; Zhou H
    Pharmacol Res; 2020 Oct; 160():105087. PubMed ID: 32683036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A 15-gene signature for prediction of colon cancer recurrence and prognosis based on SVM.
    Xu G; Zhang M; Zhu H; Xu J
    Gene; 2017 Mar; 604():33-40. PubMed ID: 27998790
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene expression and methylation profiles identified CXCL3 and CXCL8 as key genes for diagnosis and prognosis of colon adenocarcinoma.
    Zhao QQ; Jiang C; Gao Q; Zhang YY; Wang G; Chen XP; Wu SB; Tang J
    J Cell Physiol; 2020 May; 235(5):4902-4912. PubMed ID: 31709538
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of biomarkers associated with diagnosis and prognosis of colorectal cancer patients based on integrated bioinformatics analysis.
    Chen L; Lu D; Sun K; Xu Y; Hu P; Li X; Xu F
    Gene; 2019 Apr; 692():119-125. PubMed ID: 30654001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A methylation-driven gene panel predicts survival in patients with colon cancer.
    Peng Y; Zhao J; Yin F; Sharen G; Wu Q; Chen Q; Sun X; Yang J; Wang H; Zhang D
    FEBS Open Bio; 2021 Sep; 11(9):2490-2506. PubMed ID: 34184409
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic and predictive value of an autophagy-related signature for early relapse in stages I-III colon cancer.
    Mo S; Dai W; Xiang W; Li Y; Feng Y; Zhang L; Li Q; Cai G
    Carcinogenesis; 2019 Jul; 40(7):861-870. PubMed ID: 30933267
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comprehensive analysis of location-specific hub genes related to the pathogenesis of colon cancer.
    Shi C; Ding K; Li KZ; Long L; Li JL; Hu BL
    Med Oncol; 2020 Aug; 37(9):77. PubMed ID: 32743717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of candidate diagnostic and prognostic biomarkers for pancreatic carcinoma.
    Cheng Y; Wang K; Geng L; Sun J; Xu W; Liu D; Gong S; Zhu Y
    EBioMedicine; 2019 Feb; 40():382-393. PubMed ID: 30639415
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LOXL2 Is Highly Expressed in Cancer-Associated Fibroblasts and Associates to Poor Colon Cancer Survival.
    Torres S; Garcia-Palmero I; Herrera M; Bartolomé RA; Peña C; Fernandez-Aceñero MJ; Padilla G; Peláez-García A; Lopez-Lucendo M; Rodriguez-Merlo R; García de Herreros A; Bonilla F; Casal JI
    Clin Cancer Res; 2015 Nov; 21(21):4892-902. PubMed ID: 26206869
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic and predictive value of a microRNA signature in stage II colon cancer: a microRNA expression analysis.
    Zhang JX; Song W; Chen ZH; Wei JH; Liao YJ; Lei J; Hu M; Chen GZ; Liao B; Lu J; Zhao HW; Chen W; He YL; Wang HY; Xie D; Luo JH
    Lancet Oncol; 2013 Dec; 14(13):1295-306. PubMed ID: 24239208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification and Clinical Validation of a Novel 4 Gene-Signature with Prognostic Utility in Colorectal Cancer.
    Ahluwalia P; Mondal AK; Bloomer C; Fulzele S; Jones K; Ananth S; Gahlay GK; Heneidi S; Rojiani AM; Kota V; Kolhe R
    Int J Mol Sci; 2019 Aug; 20(15):. PubMed ID: 31387239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcriptome profiling reveals an integrated mRNA-lncRNA signature with predictive value of early relapse in colon cancer.
    Dai W; Feng Y; Mo S; Xiang W; Li Q; Wang R; Xu Y; Cai G
    Carcinogenesis; 2018 Oct; 39(10):1235-1244. PubMed ID: 29982331
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Construction of ceRNA networks reveals differences between distal and proximal colon cancers.
    Qian W; Feng Y; Li J; Peng W; Gu Q; Zhang Z; Ji D; Wang Q; Zhang D; Sun Y
    Oncol Rep; 2019 May; 41(5):3027-3040. PubMed ID: 30896838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and RNA expression integrated signature for urothelial bladder cancer prognosis.
    Xiong J; Xiong K; Bing Z
    Cancer Biomark; 2018 Feb; 21(3):535-546. PubMed ID: 29226853
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.